Patents by Inventor Maria Dolores Tobalina Maestre

Maria Dolores Tobalina Maestre has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120277151
    Abstract: The present invention is directed to peptide analogues of glucagon-like peptide-1, the pharmaceutically-acceptable salts thereof, to methods of using such analogues to treat mammals and to pharmaceutical compositions useful therefore comprising said analogues.
    Type: Application
    Filed: July 9, 2012
    Publication date: November 1, 2012
    Applicant: IPSEN PHARMA S.A.S.
    Inventors: Resurreccion ALLOZA MIRAVETE, Roland CHERIF-CHEIKH, Jose-Antonio CORDERO RIGOL, Zheng Xin DONG, Frederic LACOMBE, Maria Dolores TOBALINA MAESTRE
  • Patent number: 8236759
    Abstract: The present invention is directed to peptide analogues of glucagon-like peptide-1, the pharmaceutically-acceptable salts thereof, to methods of using such analogues to treat mammals and to pharmaceutical compositions useful therefore comprising said analogues.
    Type: Grant
    Filed: June 30, 2006
    Date of Patent: August 7, 2012
    Assignee: Ipsen Pharma SAS
    Inventors: Zheng Xin Dong, Roland Cherif-Cheikh, Resurreccion Alloza Miravete, Jose-Antonio Cordero Rigol, Frederic Lacombe, Maria Dolores Tobalina Maestre
  • Publication number: 20100137204
    Abstract: The present invention is directed to peptide analogues of glucagon-like peptide-1, the pharmaceutically-acceptable salts thereof, to methods of using such analogues to treat mammals and to pharmaceutical compositions useful therefore comprising said analogues.
    Type: Application
    Filed: December 31, 2007
    Publication date: June 3, 2010
    Inventors: Zheng Xin Dong, Roland Cherif-Cheikh, Jose-Antonio Cordero-Rigol, Resurreccion Alloza Miravete, Frederic Lacombe, Maria Dolores Tobalina Maestre
  • Publication number: 20100087365
    Abstract: The present invention is directed to pharmaceutical composition comprising a clear solution or an aqueous mixture, a suspension or a semisolid of at least one peptide compound selected from the group consisting of hGLP-1(7-36)-NH2 and analogs and derivatives thereof, hGLP-1(7-37)-OH and analogs and derivatives thereof and/or exendin-4 and analogs and derivatives thereof, zinc and solvent wherein at least 95% of the said peptide compound is dissolved by the solvent.
    Type: Application
    Filed: April 13, 2007
    Publication date: April 8, 2010
    Inventors: Roland Cherif-Cheikh, Zheng Xin Dong, Maria Dolores Tobalina Maestre, Jose-Antonio Cordero-Rigol, Frederic Lacombe